Cargando...
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...
Gardado en:
| Publicado en: | Brain Behav |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/ https://ncbi.nlm.nih.gov/pubmed/28948074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|